Delay of positive list system is best FTA policy

Recently, Moon Kyung-tae, vice chairman of the Korea Pharmaceutical Manufacturers Association contributed the following articles to a local paper. - Ed.

Although its too early to tell who got the better end of the free trade agreement (FTA) reached between Korea and the U.S., one could make a reasonable argument that the deal may pose a significant threat to the country's pharmaceutical indu...